Which Patients With Low-Risk Prostate Cancer Should Receive Radiation
Robert B. Den, MD of Sidney Kimmel Medical College at Thomas Jefferson University discusses which patients with low-risk prostate cancer should receive radiation. He argues that radiation may not be f...
Author: obr
Added: 03/03/2017 (Source: Oncology Tube)
Source: Oncology Tube - March 3, 2017 Category: Cancer & Oncology Source Type: podcasts
Quality of Life for Prostate Cancer Patients: Radiation versus Surgery/Active Surveillance
Robert B. Den, MD of Sidney Kimmel Medical College at Thomas Jefferson University explains the difference between the side effects of radiation and surgery/active surveillance and which treatment impa...
Author: obr
Added: 03/03/2017 (Source: Oncology Tube)
Source: Oncology Tube - March 3, 2017 Category: Cancer & Oncology Source Type: podcasts
Use of Radiation for Advanced Prostate Cancer Treatment
Robert B. Den, MD of Sidney Kimmel Medical College at Thomas Jefferson University diseases how the use of radiation has been adopted in the treatment for advanced prostate cancer. This was recorded at...
Author: obr
Added: 03/03/2017 (Source: Oncology Tube)
Source: Oncology Tube - March 3, 2017 Category: Cancer & Oncology Source Type: podcasts
ASCO GU 2017: & quot;Best of Journals: Prostate Cancer & quot; Presentation Overview
Robert B. Den, MD of Sidney Kimmel Medical College at Thomas Jefferson University gives an overview of his presentation "Best of Journals: Prostate Cancer," which was presented at the 2017 G...
Author: obr
Added: 03/03/2017 (Source: Oncology Tube)
Source: Oncology Tube - March 3, 2017 Category: Cancer & Oncology Source Type: podcasts
How to Integrate Drugs into the Treatment of Metastatic Prostate Cancer
Nicholas J. Vogelzang, MD, FASCO, FACP of Comprehensive Cancer Centers of Nevada explains his perspective on how to integrate drugs into treating patients with metastatic prostate cancer at the 2017 G...
Author: obr
Added: 03/03/2017 (Source: Oncology Tube)
Source: Oncology Tube - March 3, 2017 Category: Cancer & Oncology Source Type: podcasts
Prostate Cancer Will Evolve to Resistance
Nicholas J. Vogelzang, MD, FASCO, FACP of Comprehensive Cancer Centers of Nevada explains how treatment for prostate cancer has changed since the emerging data on resistance. Based on his knowledge of...
Author: obr
Added: 03/03/2017 (Source: Oncology Tube)
Source: Oncology Tube - March 3, 2017 Category: Cancer & Oncology Source Type: podcasts
Will Immunotherapy Be Used for Metastatic Prostate Cancer Treatment in the Near Future
Nicholas J. Vogelzang, MD, FASCO, FACP of Comprehensive Cancer Centers of Nevada explains how and when immunotherapy will be used for metastatic prostate cancer treatments at the 2017 Genitourinary Ca...
Author: obr
Added: 03/03/2017 (Source: Oncology Tube)
Source: Oncology Tube - March 3, 2017 Category: Cancer & Oncology Source Type: podcasts
Metastatic Prostate Cancer Patients from CHAARTED and STAMPEDE Showed Major Signs of Improvement
Nicholas J. Vogelzang, MD, FASCO, FACP of Comprehensive Cancer Centers of Nevada discusses how the clinical trials, CHAARTED and STAMPEDE, have impacted his treatment for patients with metastatic horm...
Author: obr
Added: 03/03/2017 (Source: Oncology Tube)
Source: Oncology Tube - March 3, 2017 Category: Cancer & Oncology Source Type: podcasts
Chemotherapy Should Be Used as Early as Possible for Prostate Cancer Treatment
Nicholas J. Vogelzang, MD, FASCO, FACP of Comprehensive Cancer Centers of Nevada discusses when and where does chemotherapy fit into treatment for prostate cancer. He argues that chemotherapy should b...
Author: obr
Added: 03/03/2017 (Source: Oncology Tube)
Source: Oncology Tube - March 3, 2017 Category: Cancer & Oncology Source Type: podcasts
All Metastatic Castration-Resistant Prostate Cancer Patients Should Be Treated with Chemotherapy
Nicholas J. Vogelzang, MD, FASCO, FACP of Comprehensive Cancer Centers of Nevada explains why he believes that all metastatic castration-resistant prostate cancer patients should receive chemotherapy ...
Author: obr
Added: 03/03/2017 (Source: Oncology Tube)
Source: Oncology Tube - March 3, 2017 Category: Cancer & Oncology Source Type: podcasts
Should BRCA1 and BRCA2 Genetic Testing Be Added to Guidelines for Prostate Cancer--Yes
Nicholas J. Vogelzang, MD, FASCO, FACP of Comprehensive Cancer Centers of Nevada explains why BRCA 1 and BRCA 2 genetic testing should be added to the guidelines for treating prostate cancer at the 20...
Author: obr
Added: 03/03/2017 (Source: Oncology Tube)
Source: Oncology Tube - March 3, 2017 Category: Cancer & Oncology Source Type: podcasts
How Recent Data on Resistance Has Changed Advanced Prostate Cancer Treatment
Neal D. Shore, MD, FACS of Carolina Urologic Research Center explains how emerging data on resistance has changed treatment for advanced prostate cancer at the 2017 Genitourinary Cancers Symposium (AS...
Author: obr
Added: 03/01/2017 (Source: Oncology Tube)
Source: Oncology Tube - March 1, 2017 Category: Cancer & Oncology Source Type: podcasts
How did CHAARTED and STAMPEDE impact your treatment of metastatic hormone sensitive prostate cancer patients?
Neal D. Shore, MD, FACS of Carolina Urologic Research Center discusses how CHAARTED and STAMPEDE impacted his treatment for patients with metastatic hormone sensitive prostate cancer at the 2017 Genit...
Author: obr
Added: 03/01/2017 (Source: Oncology Tube)
Source: Oncology Tube - March 1, 2017 Category: Cancer & Oncology Source Type: podcasts
Where Does Chemotherapy Fit Into Prostate Cancer Treatment
Neal D. Shore, MD, FACS of Carolina Urologic Research Center discusses how and where chemotherapy fits into treating patients with prostate cancer. This was recorded at the 2017 Genitourinary Cancers ...
Author: obr
Added: 03/01/2017 (Source: Oncology Tube)
Source: Oncology Tube - March 1, 2017 Category: Cancer & Oncology Source Type: podcasts
Who are the right metastatic castration-resistant prostate cancer patients that should be treated with chemotherapy
Neal D. Shore, MD, FACS of Carolina Urologic Research Center gives his take on which metastatic castration-resistant prostate cancer patients should be treated with chemotherapy at the 2017 Genitourin...
Author: obr
Added: 03/01/2017 (Source: Oncology Tube)
Source: Oncology Tube - March 1, 2017 Category: Cancer & Oncology Source Type: podcasts
